Page last updated: 2024-08-25

clarithromycin and tachyplesin peptide, tachypleus tridentatus

clarithromycin has been researched along with tachyplesin peptide, tachypleus tridentatus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castelletti, S; Cirioni, O; Ghiselli, R; Giacometti, A; Kamysz, E; Kamysz, W; Orlando, F; Riva, A; Rocchi, M; Saba, V; Scalise, G; Silvestri, C	1

Other Studies

1 other study(ies) available for clarithromycin and tachyplesin peptide, tachypleus tridentatus

Article	Year
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12 Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Clarithromycin; Disease Models, Animal; DNA-Binding Proteins; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Humans; Male; Peptides, Cyclic; Rats; Rats, Wistar; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha	2008

Article

Year

Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.

Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12

Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Clarithromycin; Disease Models, Animal; DNA-Binding Proteins; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Humans; Male; Peptides, Cyclic; Rats; Rats, Wistar; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha

2008